Shenzhen reports to case of 3 bad reactions of his of Olli department

Shenzhen reports to case of 3 bad reactions of his of Olli department
Medicine supervises the department to remind: This medicine can cause the serious liver to damage
Recently, national food medicines supervised the administration bureau releasing his bad reaction of Olli department to notify. Yesterday, reporters learnt from Bureau of Drugs Supervision of Shenzhen, from the 1st of January, 2002 to March 7, 2011, the report of Shenzhen, about 3 cases of his of Olli department, bad reaction is shown as rash, urticaria.
He, department of Olli, long-efficiency specific gastrointestinal lipase inhibitor, can prevent triglyceride from hydrolyzing for absorptive free fatty acid and single acyl base glycerine, make it not absorbed, thus reduce heat to take in and control the weight. Suitable for the treatment of the fat or overweight patient of weight. U.S.A. FDA will announce warning, warns that he may cause the rare but serious liver to damage the risk to use reducing weight in medicine Olli department in May of 2010. Warning message claim FDA damage data, carry on overall assessment to the intersection of Olli and the intersection of department and liver of him, confirm between August of 2009 and the 1999 using the intersection of Olli and department take place at the he serious liver damage the case and amount to 13, because the depleted death of liver that among them there are 2 examples, 3 need liver transplantation.
By December 31, 2010, in the case report database of monitoring center of bad reaction of national medicines, about more than 120 case reports of his of Olli department, main bad reaction is shown as constipation, abdominal pain, diarrhoea, dizzy, period disorder, rash,etc.. And Shenzhen medicine supervises the department and measures the data to reveal from the 1st of January, 2002 to March 7, 2011 through searching, about 3 case reports of his of Olli department, bad reaction is shown as rash, urticaria.
The relevant person in charge of Bureau of Drugs Supervision of Shenzhen introduces, monitors finding after this medicine is through being listed, there are reports of rare transaminase raising, alkaline phosphatase raising and severe hepatitis after using, and the depleted case of liver appears, some patients among them need to carry on liver transplantation or cause the death directly, at present can't yet confirm concerned withing use the intersection of Olli and the intersection of department and he and serious liver damage. But consider the severity of the bad incident here, State Bureau releases information to warn medical workers and consumers and understand using the risk of this medicines in time, stop unreasonable to use medicine. Meanwhile, because this medicine is managed as non-prescribed medicine in our country, the patient can purchase medicines by oneself, hope consumers read the manual carefully, know and use Olli department correctly he pay attention to combining sports and keeping on a diet while treating fatly, could reach the good result. In addition, should also pay attention to being (such as hypertension, hyperlipemia, diabetes) to the fat complication Monitoring and treating,until manual will appear there damage is liver described and at the time of symptoms relevant of bad reactions seriouses other, should seek medical advice in time.

|